HAPIMMUNE THERAPEUTICS
Dead / Abandoned — Abandoned — no statement of use filed (as of 26 Oct 2026)
What this means for you
This application is over — abandoned 26 Oct 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97590386
- Mark type
- Word mark
- Filed
- 14 Sept 2022
- Published for opposition
- 01 Aug 2023
- Abandoned
- 26 Oct 2026
- Attorney of record
- Aaron D. Hendelman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
- Class 042 — Scientific and technological services: Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics
Owner
- AETHON THERAPEUTICS, INC., Long Island City, NY, US
- AETHON THERAPEUTICS, INC., NEW YORK, NY, US
- Sixth Sense Health LLC, NEW YORK, NY, US
Prosecution history
- 26 Oct 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 26 Oct 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 23 Jul 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Jul 2026 — SOU EXTENSION 5 GRANTED
- 12 Mar 2026 — SOU EXTENSION 5 FILED
- 22 Jul 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Sept 2025 — SOU EXTENSION 4 GRANTED
- 09 Sept 2025 — SOU EXTENSION 4 FILED
- 09 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 19 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Mar 2025 — SOU EXTENSION 3 GRANTED
- 18 Mar 2025 — SOU EXTENSION 3 FILED
- 18 Mar 2025 — SOU TEAS EXTENSION RECEIVED